← Leaderboards
Daniel Chung
University Of Pennsylvania
$838,490
Attributed
$838,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.1K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$838,490 · 1
By mechanism
K08$838,490 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Gustavo David Aguirre$22,398,317
- William A. Beltran$14,525,140
- Samuel G Jacobson$12,402,167
- Eric A Pierce$25,662,965
- Artur V Cideciyan$5,096,772
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsAnimal ModelAnimalsBacteriophagesBiochemicalBlindnessComplementary TherapiesCostDegenerative DisorderElectroporationEngineeringEvaluationExhibitsFundingGenesGene TargetingGene TherapyGene TransferInheritedIntegraseIn VitroIn VivoKnockout AnimalAdult
Grant awards (6)
non-viral medicated gene targeting to the retina$153,858
K08 · FY2010 · EY · contact PI
non-viral medicated gene targeting to the retina$149,376
K08 · FY2009 · EY · contact PI
non-viral medicated gene targeting to the retina$112,730
K08 · FY2009 · EY · contact PI
non-viral medicated gene targeting to the retina$145,025
K08 · FY2008 · EY · contact PI
non-viral medicated gene targeting to the retina$140,801
K08 · FY2007 · EY · contact PI
non-viral medicated gene targeting to the retina$136,700
K08 · FY2006 · EY · contact PI